Showing results (11-20 of 215) with videos related to

Sort By:
Pageof 22
European Journal of Cancer (Oxford, England : 1990)|February 23, 2002
Highlights and strategies of the EORTC Leukemia Group. European Organisation for Research and Treatment of CancerT de Witte, J-P Marie, S Suciu, et al.
Scandinavian Journal of Haematology|November 1, 1985
Repetitive cycles of cytoreductive therapy followed by stem cell autografting for nonlymphoblastic transformation of chronic granulocytic leukaemiaT de Witte, R Raymakers, B de Pauw, et al.
Bone Marrow Transplantation|July 26, 2011
Current status of hematopoietic cell transplantation in the treatment of systemic amyloid light-chain amyloidosisS O Schönland, P Dreger, T de Witte, et al.
Bone Marrow Transplantation|December 1, 1986
Monitoring of cyclosporin during continuous intravenous administrationT de Witte, A Hoitsma, M M Manoiu, et al.
Cancer|September 1, 1990
Intensive antileukemic treatment of patients younger than 65 years with myelodysplastic syndromes and secondary acute myelogenous leukemiaT De Witte, P Muus, B De Pauw, et al.
Leukemia|October 1, 2004
Inhibitor of apoptosis proteins: new therapeutic targets in hematological cancer?A O de Graaf, T de Witte, J H Jansen
Bone Marrow Transplantation|December 1, 1989
Intensive chemotherapy for patients with myelodysplastic syndromes and acute myelogenous leukaemia younger than 65 yearsT De Witte, P Muus, B De Pauw, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|December 24, 1997
Heme induces the expression of adhesion molecules ICAM-1, VCAM-1, and E selectin in vascular endothelial cellsF A Wagener, E Feldman, T de Witte, et al.
European Journal of Haematology|March 1, 1993
Plasma and cellular pharmacokinetics of m-AMSA related to in vitro toxicity towards normal and leukemic clonogenic bone marrow cells (CFU-GM, CFU-L)P Linssen, P Brons, G Knops, et al.
Bone Marrow Transplantation|March 1, 1989
Prevention of leukemic relapse after transplantation with lymphocyte depleted marrow by intensification of the conditioning regimen with a 6-day continuous infusion of anthracyclinesJ Raemaekers, T De Witte, A Schattenberg, et al.
Pageof 22